Artificial intelligence versus clinicians: systematic review of design, reporting standards, and claims of deep learning studies
暂无分享,去创建一个
J. Ioannidis | G. Collins | E. Topol | M. Komorowski | A. Gordon | H. Harvey | M. Maruthappu | M. Nagendran | Yang Chen | C. Lovejoy
[1] J. Ioannidis,et al. Reproducible research practices, transparency, and open access data in the biomedical literature, 2015–2017 , 2018, PLoS biology.
[2] G. Collins,et al. Uniformity in measuring adherence to reporting guidelines: the example of TRIPOD for assessing completeness of reporting of prediction model studies , 2019, BMJ Open.
[3] M. Ratner. FDA backs clinician-free AI imaging diagnostic tools , 2018, Nature Biotechnology.
[4] D. Moher,et al. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials , 2010, Journal of clinical epidemiology.
[5] T. Berzin,et al. Real-time automatic detection system increases colonoscopic polyp and adenoma detection rates: a prospective randomised controlled study , 2019, Gut.
[6] Gary S Collins,et al. Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration , 2015, Annals of Internal Medicine.
[7] Karel Moons,et al. PROBAST: A Tool to Assess Risk of Bias and Applicability of Prediction Model Studies: Explanation and Elaboration , 2019, Annals of Internal Medicine.
[8] I. Boutron,et al. Three randomized controlled trials evaluating the impact of “spin” in health news stories reporting studies of pharmacologic treatments on patients’/caregivers’ interpretation of treatment benefit , 2019, BMC Medicine.
[9] G. Collins,et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement , 2015, BMJ : British Medical Journal.
[10] Andre Esteva,et al. A guide to deep learning in healthcare , 2019, Nature Medicine.
[11] R. Tibshirani,et al. Increasing value and reducing waste in research design, conduct, and analysis , 2014, The Lancet.
[12] Woohyung Lim,et al. Deep neural networks show an equivalent and often superior performance to dermatologists in onychomycosis diagnosis: Automatic construction of onychomycosis datasets by region-based convolutional deep neural network , 2018, PloS one.
[13] et al.,et al. Framework for the impact analysis and implementation of Clinical Prediction Rules (CPRs) , 2011, BMC Medical Informatics Decis. Mak..
[14] B. Psaty,et al. COX-2 inhibitors--lessons in drug safety. , 2005, The New England journal of medicine.
[15] D. DeMets,et al. Surrogate End Points in Clinical Trials: Are We Being Misled? , 1996, Annals of Internal Medicine.
[16] C. Bias. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials , 2011 .
[17] John Hoey,et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. , 2005, The New England journal of medicine.
[18] G. Collins,et al. Artificial Intelligence Algorithms for Medical Prediction Should Be Nonproprietary and Readily Available. , 2019, JAMA internal medicine.
[19] Bibb Allen. The Role of the FDA in Ensuring the Safety and Efficacy of Artificial Intelligence Software and Devices. , 2019, Journal of the American College of Radiology : JACR.
[20] Xiaohang Wu,et al. Diagnostic Efficacy and Therapeutic Decision-making Capacity of an Artificial Intelligence Platform for Childhood Cataracts in Eye Clinics: A Multicentre Randomized Controlled Trial , 2019, EClinicalMedicine.
[21] John Hoey,et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. , 2005, Circulation.
[22] Kristian Thorlund,et al. Reanalyses of randomized clinical trial data. , 2014, JAMA.
[23] Sinan Aral,et al. The spread of true and false news online , 2018, Science.
[24] J. Sterne,et al. The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.
[25] Geoffrey E. Hinton,et al. Deep Learning , 2015, Nature.
[26] G. Collins,et al. PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies , 2019, Annals of Internal Medicine.
[27] Rayid Ghani,et al. Machine learning and AI research for Patient Benefit: 20 Critical Questions on Transparency, Replicability, Ethics and Effectiveness , 2018, ArXiv.
[28] David Moher,et al. Reducing waste from incomplete or unusable reports of biomedical research , 2014, The Lancet.
[29] Petroc Sumner,et al. Exaggerations and Caveats in Press Releases and Health-Related Science News , 2016, PloS one.
[30] Brian A. Nosek,et al. Evaluating the replicability of social science experiments in Nature and Science between 2010 and 2015 , 2018, Nature Human Behaviour.
[31] Gary S. Collins,et al. Reporting of artificial intelligence prediction models , 2019, The Lancet.
[32] C. Kalkman,et al. Evaluating the impact of prediction models: lessons learned, challenges, and recommendations , 2018, Diagnostic and Prognostic Research.
[33] Eric J Topol,et al. High-performance medicine: the convergence of human and artificial intelligence , 2019, Nature Medicine.
[34] Shih-Hwa Chiou,et al. Artificial intelligence-based decision-making for age-related macular degeneration , 2019, Theranostics.
[35] D. Moher,et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement , 2009, BMJ.